Literature DB >> 29052156

The Identification, Review and Synthesis of Health State Utility Values from the Literature.

Roberta Ara1, John Brazier1, Tessa Peasgood2, Suzy Paisley1.   

Abstract

Systematic literature reviews of health-related quality of life (HRQoL) evidence that are to inform economic models can be challenging due to the volume of hits identified in searches using generic terms for HRQoL. Nevertheless, a robust review of the literature is required to ensure that the health state utility values (HSUVs) used in the economic model are the most appropriate available. This article provides a synopsis of literature relating to identifying, reviewing and synthesising HSUVs. The process begins with scoping the needs of the economic model, including the definitions of health states and the requirements of any reimbursement agencies. A sequence of searches may be required as the economic model evolves. The terminology used for HRQoL measures may be problematic, and as there is no robust HRQoL filter [equivalent to that applied for randomised control trial (RCTs)], sifting the results of sensitive searches can be resource intensive. Alternative approaches such as forward and backward citation searches may reduce the resources required, while maintaining the integrity of the search. Any included studies should be assessed in terms of quality using a recommended checklist, and insufficient detail in the primary studies should be noted as a short-coming in this exercise. Subject to homogeneity (similar populations, same measure and preference weights) evidence can be pooled in some way, although methodological research into the appropriateness of alternative techniques for meta-analysis is in its infancy. Reporting standards are key and as a minimum should include details on searches, inclusion/exclusion criteria (together with rationale for exclusion at each stage), assessment of quality and relevance of included studies, and justification for the choice of final HSUVs.

Entities:  

Mesh:

Year:  2017        PMID: 29052156     DOI: 10.1007/s40273-017-0547-8

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  10 in total

1.  Controlling the risk of spurious findings from meta-regression.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

2.  Systematic searching and selection of health state utility values from the literature.

Authors:  Diana Papaioannou; John Brazier; Suzy Paisley
Journal:  Value Health       Date:  2013-06       Impact factor: 5.725

3.  Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.

Authors:  Sorrel E Wolowacz; Andrew Briggs; Vasily Belozeroff; Philip Clarke; Lynda Doward; Ron Goeree; Andrew Lloyd; Richard Norman
Journal:  Value Health       Date:  2016 Sep - Oct       Impact factor: 5.725

Review 4.  The Use of Mapping to Estimate Health State Utility Values.

Authors:  Roberta Ara; Donna Rowen; Clara Mukuria
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 5.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 6.  The burden of neuropathic pain: a systematic review and meta-analysis of health utilities.

Authors:  Alissa H Doth; Per T Hansson; Mark P Jensen; Rod S Taylor
Journal:  Pain       Date:  2010-03-15       Impact factor: 6.961

Review 7.  Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

Authors:  J A Kanis; M Stevenson; E V McCloskey; S Davis; M Lloyd-Jones
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

Review 8.  An updated systematic review of Health State Utility Values for osteoporosis related conditions.

Authors:  T Peasgood; K Herrmann; J A Kanis; J E Brazier
Journal:  Osteoporos Int       Date:  2009-03-07       Impact factor: 4.507

Review 9.  A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.

Authors:  John Brazier; Roberta Ara; Donna Rowen; Helene Chevrou-Severac
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 10.  Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?

Authors:  Tessa Peasgood; John Brazier
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

  10 in total
  15 in total

1.  Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.

Authors:  Nathaniel Hendrix; David D Kim; Krishna S Patel; Beth Devine
Journal:  Med Decis Making       Date:  2021-01-15       Impact factor: 2.583

2.  Heath State Utility Values for Cost-Effectiveness Models.

Authors:  Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 3.  Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies.

Authors:  Roberta Ara; John Brazier; Tracey Young
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 4.  The Use of Mapping to Estimate Health State Utility Values.

Authors:  Roberta Ara; Donna Rowen; Clara Mukuria
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

5.  Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity.

Authors:  Susanne Schmitz; Tatjana T Makovski; Roisin Adams; Marjan van den Akker; Saverio Stranges; Maurice P Zeegers
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

6.  Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review.

Authors:  Boshen Jiao; Anirban Basu; Scott Ramsey; Joshua Roth; M A Bender; Dalyna Quach; Beth Devine
Journal:  Value Health       Date:  2021-09-04       Impact factor: 5.725

Review 7.  The Use of Health State Utility Values in Decision Models.

Authors:  Roberta Ara; John Brazier; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

8.  A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values.

Authors:  Stavros Petrou; Joseph Kwon; Jason Madan
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

Review 9.  Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study.

Authors:  Brett Doble; Maria Pufulete; Jessica M Harris; Tom Johnson; Daniel Lasserson; Barnaby C Reeves; Sarah Wordsworth
Journal:  Health Qual Life Outcomes       Date:  2018-09-20       Impact factor: 3.186

10.  Association of Hair Loss With Health Utility Measurements Before and After Hair Transplant Surgery in Men and Women.

Authors:  Nicholas B Abt; Olivia Quatela; Alyssa Heiser; Nate Jowett; Oren Tessler; Linda N Lee
Journal:  JAMA Facial Plast Surg       Date:  2018-12-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.